Medication Safety & Detox Governance

This page outlines the policies, clinical protocols, and safety systems that govern the prescribing, storage, administration, and monitoring of medications at Siam Rehab. Our approach aligns with international best practice for residential addiction treatment and detox programmes, ensuring safe, evidence-based care for all clients.

1. Governance Framework for Medication Safety

Medication safety at Siam Rehab is overseen by our Medical Director and governed by a structured framework that includes clinical policies, risk-management procedures, and internal audits. Key components include:

• Clear prescribing authority limited to licensed medical practitioners;
• Daily nursing oversight for medication administration and monitoring;
• Secure storage systems with documented access logs;
• Routine reconciliation of medication records against stock levels;
• Standardised detox pathways with validated risk-assessment tools;
• Defined escalation processes for medical instability or withdrawal complications.

2. Prescribing Protocols

All medications are prescribed exclusively by the on-site psychiatrist or, where applicable, a collaborating medical officer. Prescribing follows a structured protocol designed to minimise risks associated with withdrawal, co-occurring conditions, and potential drug interactions.

Core prescribing principles include:

• Individualised medication plans based on medical history and risk category;
• Use of evidence-based detox regimens (for alcohol, benzodiazepines, opioids, stimulants, and mixed-use profiles);
• Avoidance of potentially dependence-forming medications unless clinically necessary;
• Daily review during acute detox and weekly review thereafter;
• Documentation in a secure electronic medication-administration record (eMAR).

3. Detox Risk Stratification

Every client undergoes detox risk stratification on admission using validated criteria. Clients are categorised as Low, Moderate, or High risk based on substance type, quantity, duration of use, previous withdrawal outcomes, and co-morbidities.

Clients assessed as High risk are stabilised in hospital prior to joining the residential programme. Moderate-risk clients receive enhanced monitoring during the first 3–5 days of detox, including vital-sign checks and scheduled nursing rounds. Low-risk clients follow a standard protocol with symptom-triggered dosing if clinically indicated.

4. Medication Administration & Monitoring

Medication administration is conducted by licensed nursing staff following a “double-check” procedure to reduce risk of error. All administrations are logged in the eMAR system, including the dose, time, client identity, administering nurse, and any clinical comments.

Key monitoring parameters include:

• Vital signs (blood pressure, pulse, respiratory rate, temperature);
• Withdrawal severity (CIWA-Ar, COWS, or stimulant withdrawal scales);
• Mental-status changes;
• Medication side effects;
• Sleep quality and agitation;
• Cravings intensity.

These indicators allow us to identify early signs of complications such as seizures, delirium tremens, oversedation, arrhythmia, or severe anxiety.

5. Secure Storage & Inventory Control

Medication storage complies with national regulations and international standards for addiction-treatment facilities. Measures include:

• Locked medication room with restricted access;
• Controlled substances kept in a separate double-locked cabinet;
• Temperature-controlled storage where required;
• Daily stock reconciliation for controlled medications;
• Weekly full-inventory audits;
• Incident logs for discrepancies, near-misses, or break-seal events.

6. Detox Outcomes & Complication Rates

Between 2022 and 2025, medication-assisted detox at Siam Rehab showed strong safety indicators with low rates of adverse events. Complications are categorised into mild, moderate, or severe, based on clinical impact and whether external medical care was required.

These rates align with international benchmarks for residential detox programmes, especially considering the high proportion of clients with long-term alcohol use and dual diagnosis presentations.

7. Medication Side-Effects Monitoring

Every medication administered carries a risk of side effects. Our system tracks both expected and unexpected reactions, which are reviewed weekly during clinical meetings and monthly in governance reports.

Most side effects observed during treatment are mild and self-limiting. Moderate reactions typically involve changes to the medication plan, while severe reactions require hospital evaluation.

8. Escalation & Hospital Transfer Criteria

Escalation to hospital is guided by defined clinical thresholds, ensuring prompt and safe transfer when necessary. These indicators include:

• Uncontrolled withdrawal despite medication;
• Signs of delirium tremens;
• Seizures or pre-seizure activity;
• Cardiovascular instability;
• Severe electrolyte abnormalities;
• Suicidal ideation with intent or severe agitation;
• Suspected intoxication while in treatment;
• Acute psychosis or dissociation.

9. Medication Safety Audits & Quality Improvement

Medication safety is continuously monitored through internal audits, incident reviews, and governance meetings. Audit findings guide programme refinement and staff training. Our audit cycle includes:

• Daily eMAR spot checks;
• Weekly dose-variance audits;
• Monthly controlled-substance inventory audits;
• Quarterly storage-compliance reviews;
• Annual external governance audit.

10. What Medication Safety Means for Clients & Families

Medication safety is at the heart of our detox and treatment model. By combining evidence-based prescribing, structured monitoring, secure storage, and clear escalation pathways, we deliver a detox environment that is both safe and clinically robust.

This transparency helps clients and families make informed decisions about treatment, especially when navigating the risks associated with detox from alcohol, benzodiazepines, opioids, stimulants, or poly-substance use.